Piramal Pharma announces consolidated results for Q2 and H1 FY2023
Revenue from operation grew by 11 per cent to Rs 3,202 crore versus Rs 2,889 crore in H1FY22
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Balaxi Pharma reports 23 per cent growth YoY during Q2FY23
Pharma revenue up 50 per cent with expanding contribution from Latin America
Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables
The drug major also plans to utilise the capital for adding capacities to existing plants, firm up R&D activities and further…
Pharma industry reports 79 M&A deals in October 2022
The industry reported 102 Venture Capital (VC) deals worth $1.8 billion in October 2022, compared to the last 12-month average…
Hester Bosciences announces results for Q2 and H1 FY23
The company has achieved the highest quarterly sales in its history
Moderna COVID vaccine sales forecasts fall short for 2022, 2023
The company did say the 2023 outlook excludes expected contracts with countries such as the US and Japan, and that it anticipated…
Persisting cost inflation and pricing pressures impact pharma industry: ICRA
The outlook for the Indian pharma industry remains stable, led by expectations of continued steady revenue growth and comfortable…
CPHI Frankfurt 2022: Global pharma hits record high in annual CPhI Pharma Index
Growth and quality scores improved dramatically across all markets, with India the overall biggest winner
Dr Reddy’s announces financial results for Q2 and H1 FY23
EBITDA is at Rs 19.3 billion and the EBITDA margin is 30.6 per cent
AGI Greenpac Q2 FY23 revenue from operations stands at Rs 513 crore
EBITDA up 17 per cent to Rs 87 crore on Year on Year (YoY) basis
Sanofi sees faster profit growth on Dupixent, flu vaccine
Sanofi reported a 26.5 per cent rise in third-quarter business operating income, or adjusted earnings before interest and tax, to…
Pfizer COVID vaccine price hike seen giving revenue boost for years
The drugmaker, which developed and sells the vaccine with Germany's BioNTech said last week that it is targetting a range of $110…
Biogen raises annual profit forecast for second straight quarter
Data on the drug has been promising and Biogen and Eisai are expected to file for a US approval soon with a decision expected in…
Eris Lifesciences’s Q2FY23 revenue up 28 per cent YoY
EBITDA at Rs 1,514 million, with 32.9 per cent EBITDA margin; PAT stood at Rs 1,194 million, with 25.9 per cent PAT margin
Lupin to acquire two inhalation brands from Sunovion for $75 million
Brovana is indicated for long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary…
Syngene reports Q2 results
Revenue from operations up 26 per cent to Rs 768 crore, PAT increased 11 per cent to Rs 102 crore
Citeline gives insights on longer-term outlook at some key late-stage drugs projected to hit market…
These drugs represent new drug classes, major changes to standards of care and large market opportunities across the globe
Pharma industry’s deal value decreases by 74.8 per cent in September 2022
Venture capital investments decreased by 45.8 per cent in September 2022, compared to September 2021
Indian Immunologicals announces its foray into Aquaculture health market
IIL’s foray into aquaculture segment will be in multiple phases comprising multiple products, including vaccines
IQVIA and Dr Reddy’s partner for CRM solution
Dr Reddy’s will rollout IQVIA’s OCE application to its entire field force and marketing users in India to drive more meaningful…